TNF and type 1 diabetes mellitus: Based on the workshop, this perspective highlights evidence for the beneficial use of TNF-α inhibitors in T1D and outlines considerations and strategies collectively identified to advance TNF-α inhibitors beyond phase 2 clinical studies for stage 3 T1D.